中国药典2025年版注射剂可见异物控制指导原则解读

    Interpretation of the Guidelines for the Control of Visible Particulates in Injections in Chinese Pharmacopoeia 2025 Edition

    • 摘要:
      目的 解析中国药典2025年版新增的《注射剂可见异物控制指导原则》(通则9016)核心要义,指导行业准确理解药品全生命周期质量管理理念,优化注射剂可见异物控制体系,推动新标准有效实施。
      方法 基于指导原则起草背景,系统解读在可见异物来源、检测方法、过程控制和风险分析等方面的相关规定。
      结果 指导原则系统性归纳了可见异物的两类来源,对比解析现有检查程序及方法,研究提炼出了“预防-控制-监测”三位一体的全生命周期控制理念。
      结论 指导原则的制定标志着中国注射剂质量控制进入风险管理新阶段,通过系统化的过程控制方法和科学化的风险分析工具,可有效提升可见异物防控水平,为注射剂质量控制提供技术支撑,保障临床用药安全。

       

      Abstract:
      OBJECTIVE To analyse the core meaning of the new Guidelines for the Control of Visible Particulates in Injections(General Chapter 9016) added to the Chinese Pharmacopoeia 2025 Edition, guide the industry to accurately understand the concept of quality management of the whole life cycle of medicines, optimize the system of controlling visible particulates in injections, and promote the effective implementation of the new standard.
      METHODS Based on the background of the drafting of the guiding principles, systematically interpreted the relevant provisions on the sources of visible foreign particulates, detection methods, process control and risk analysis.
      RESULTS The guidelines systematically summarized the two types of sources of visible particulates, compared and analyzed existing inspection procedures and methods, and the study refined the concept of “prevention-control-monitoring” as a trinity of the whole life cycle control.
      CONCLUSION The formulation of the guiding principles marks a new stage of risk management for the quality control of injection in China, which can effectively improve the level of prevention and control of visible foreign particulates through systematic process control methods and scientific risk analysis tools, provide technical support for the quality control of injection, and safeguard the safety of clinical use of drugs.

       

    /

    返回文章
    返回